Structure Therapeutics Oral GLP-1 Obesity Drug Achieves ‘Injectable-Like Efficacy’ in Phase 2 Test
Construction Therapeutics’ aleniglipron, a once-daily oral GLP-1 drug, led to a mean 16% weight reduction measured at 44 weeks. Primarily ...
Construction Therapeutics’ aleniglipron, a once-daily oral GLP-1 drug, led to a mean 16% weight reduction measured at 44 weeks. Primarily ...
Fondazione Telethon announces the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European ...
Graphical Abstract: Schematic representation of 3-step HER2-targeted 225Ac-PRIT, 225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenograft, and representative ...
A daily pill version of GLP-1 therapy shows strong 72-week weight loss and metabolic improvements, offering a practical alternative to ...
New research being presented at this year's European Congress on Obesity (ECO 2025) has found that patients of an online ...
Dr. Javier Briones, researcher at Sant Pau Research Institute (IR Sant Pau) and Josep Carreras Leukemia Research Institute. Credit: Josep ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.